661 patents currently held
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
103
Ending by 2030
Jan 2027
Next term end
469
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2032 · High confidence
Also notable
Ends Mar 2031 · High confidence
Also notable
Ends Apr 2035 · Medium confidence
Also notable
Ends Apr 2033 · High confidence
Also notable
Ends Jul 2032 · High confidence
Also notable
Ends Jun 2035 · High confidence
Also notable
Ends May 2028 · High confidence
Also notable
Ends Feb 2039 · High confidence
In-Situ Forming Foams for Treatment of Aneurysms
US 10,420,862
Cited by 50 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2032.
Nanoporous Stents with Enhanced Cellular Adhesion and Reduced Neointimal Formation
US 9,770,349
Cited by 37 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Delivery Device for Prosthetic Heart Valve with Capsule Adjustment Device
US 10,327,899
Cited by 41 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Prosthetic Mitral Valve and Delivery Method
US 9,023,099
Cited by 418 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Controlled Tip Release Stent Graft Delivery System and Method
US 9,775,706
Cited by 219 later US patents, top 1% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Prosthetic Valve Support Structure
US 9,918,833
Cited by 189 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Coronary Sinus Approach for Repair of Mitral Valve Regurgitation
US 7,955,384
Cited by 144 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Crosslinkable Polymer Compositions
US 11,311,648
Cited by 9 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Blow-Molded Package for a Catheter (US 9,038,822) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 9 fees due Dec 16 to 30, 2026 · next Dec 16
- 5 fees due Jan 4 to 25, 2027 · next Jan 4
- 10 fees due Feb 4 to 25, 2027 · next Feb 4
- 12 fees due Mar 1 to 26, 2027 · next Mar 1
- 19 fees due Apr 1 to 30, 2027 · next Apr 1
- 13 fees due May 3 to 28, 2027 · next May 3
- 15 fees due Jun 3 to 30, 2027 · next Jun 3
- 12 fees due Jul 5 to 28, 2027 · next Jul 5
- 7 fees due Aug 9 to 23, 2027 · next Aug 9
- 12 fees due Sep 1 to 30, 2027 · next Sep 1
- 13 fees due Oct 5 to 30, 2027 · next Oct 5
- 9 fees due Nov 3 to 17, 2027 · next Nov 3
Recent changes
- 12 of the patents on this record were granted since Aug 23, 2026
- 17 terms have ended since Aug 23, 2026
- Oct 31 US 7,655,040 Cardiac Valve Annulus Reduction System · term ended
- Oct 28 US 8,873,900 Balloon Catheter with Integrated Optical Sensor for Determining Balloon Diameter · lapsed on the fee record
- Oct 21 US 8,864,786 Dual-Layer Medical Balloon and Process of Making · lapsed on the fee record
- Oct 21 US 8,864,676 Implantable Medical Sensor and Fixation System · lapsed on the fee record
- Oct 20 US 7,713,573 Method for Loading Nanoporous Layers with Therapeutic Agent · term ended
- Oct 16 US 10,098,767 Reconfigurable Stent-Graft Delivery System and Method of Use · lapsed on the fee record
- Oct 11 US 11,464,946 Chordae Tendineae Management Devices for Use with a Valve Prosthesis Delivery System and Methods of Use Thereof · lapsed on the fee record
- Oct 9 US 10,092,297 Tissue Compression Device with Fixation and Tension Straps · lapsed on the fee record
- Oct 8 US 7,442,207 Device, System, and Method for Treating Cardiac Valve Regurgitation · term ended
- Oct 7 US 8,850,676 Guidewire Loading Tool For A Catheter · lapsed on the fee record
- Sep 30 US 8,845,588 Sheath Introducer System with Exchangeable Hemostatic Valves · lapsed on the fee record
- Sep 25 US 10,517,748 Prosthesis with Guide Lumen · term ended
- Sep 16 US 8,834,499 Percutaneous Methods and Apparatus for Creating Native Tissue Venous Valves · lapsed on the fee record
- Sep 9 US 8,831,741 Catheter With Deflectable Cap · lapsed on the fee record
- Sep 9 US 8,828,474 Apparatus and Methods for Loading a Drug Eluting Medical Device · lapsed on the fee record
What they patent
The largest of its 469 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,635,382 | Delivery System for Long Self-Expanding Stents In force · High confidence | In force | High confidence | |
| US 7,442,721 | Durable Biocompatible Controlled Drug Release Polymeric Coatings for Medical Devices In force · High confidence | In force | High confidence | |
| US 8,214,015 | In Vivo Localization and Tracking of Tissue Penetrating Catheters Using Magnetic Resonance Imaging In force · Medium confidence | In force | Medium confidence | |
| US 11,504,223 | Methods and Apparatus for Treatment of Aneurysms Adjacent Branch Arteries In force · High confidence | In force | High confidence | |
| US 7,828,832 | Intravascular Deployment Device with Improved Deployment Capability In force · High confidence | In force | High confidence | |
| US 7,524,331 | Catheter Delivered Valve Having a Barrier to Provide an Enhanced Seal In force · High confidence | In force | High confidence | |
| US 7,481,836 | Prosthesis with Coupling Zone and Methods In force · High confidence | In force | High confidence | |
| US 10,307,244 | Methods and Apparatus for Treatment of Aneurysms Adjacent Branch Arteries In force · High confidence | In force | High confidence | |
| US 7,591,848 | Riveted Stent Valve for Percutaneous Use In force · High confidence | In force | High confidence | |
| US 7,651,527 | Bioresorbable Stent In force · High confidence | In force | High confidence |
Also on record, not counted in the 661: 8 patents in force now held by others · 329 patents ended · 109 applications pending · 560 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.